Hostname: page-component-745bb68f8f-f46jp Total loading time: 0 Render date: 2025-01-23T05:48:57.754Z Has data issue: false hasContentIssue false
  • English
  • Français

Alleviation of the Psychological Effects of LSD in Man by 5-Hydroxytryptophan

Published online by Cambridge University Press:  08 February 2018

J. C. Brengelmann ,
C. M. B. Pare  and
M. Sandler
J. C. Brengelmann
Affiliation:
Institute of Psychiatry, Maudsley Hospital, London, S.E.5
C. M. B. Pare
Affiliation:
Bethlem Royal and the Maudsley Hospital, London, S.E.5
M. Sandler
Affiliation:
Royal Free Hospital, London, W.C.1
Get access Rights & Permissions [Opens in a new window]

Extract

In the investigation described, the hypothesis was tested that 5-hydroxytryptamine (5HT) acts to reduce the psychological effects of lysergic acid diethylamide (LSD). The method was to inject 5-hydroxytryptophan (5HTP) prior to LSD and to compare the results of psychological tests performed after these injections. Placebo controls were used.

Type
Original Articles
Information
Journal of Mental Science , Volume 104 , Issue 437 , October 1958 , pp. 1237 - 1244
Copyright
Copyright © Royal College of Psychiatrists, 1958 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Amin, A. H., Crawford, T. B. B., and Gaddum, J. H., “The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog”, J. Physiol., 1954, 126, 596.CrossRefGoogle Scholar
Brengelmann, J. C., “Effects of LSD-25 on tests of personality”, J. Ment. Sci., 1958, 104, 1226.Google Scholar
Brodie, B. B., Pletscher, A., and Shore, P. A., “Evidence that serotonin has a role in brain function”, Science, 1955, 122, 968.Google Scholar
Idem , Tomich, E. G., Kuntzman, R., and Shore, P. A., “On the mechanism of action of reserpine: effect of reserpine on capacity of tissues to brain serotonin”, J. Pharmacol. exp. Therap., 1957, 119, 461.Google Scholar
Cerletti, A., and Rothlin, E., “Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives”, Nature, London, 1955, 176, 785–786.Google Scholar
Costa, E., “The effects of hallucinogenic and tranquillizing drugs on the serotonin evoked uterine contractions”, Psychiat. Res. Rep., 1956, 4, 11–23.Google Scholar
Davidson, J., Sjoerdsma, A., Loomis, L. N., and Udenfriend, S., “Studies with the serotonin precursor, 5-hydroxytryptophan, in experimental animals and man”, J. clin. Invest., 1957, 36, 1594–1599.CrossRefGoogle Scholar
Erspamer, V., “Some observations on the fate of exogenous 5-hydroxytryptamine (enteramine) in the rat”, J. Physiol., 1956, 133, 1–9.Google Scholar
Gaddum, J. H., “Tryptamine receptors”, J. Physiol., 1953a, 119, 363–368.Google Scholar
Idem , “Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine”, J. Physiol., 1953b, 121, 15.Google Scholar
Idem , “Recent work on 5-hydroxytryptamine and lysergic acid derivatives”, XXth International Congress of Physiology, Brussels, 1956. Volume I (Résumé de rapports), 442–455.Google Scholar
Hare, R. S., “Endogenous creatinine in serum and urine”, Proc. soc. exp. Biol., N.Y., 1950, 74, 148–151.Google Scholar
Isbell, H., and Logan, C. R., “Studies on the diethylamide of lysergic acid (LSD-25)”, Arch. Neurol. Psychiat., 1957, 77, 350–358.Google Scholar
Jepson, J. B., “Paper chromatography of urinary indoles”, Lancet, 1955, ii 1009–1011.Google Scholar
Idem and Stevens, B. J., “A fluorescence test for serotonin and other tryptamines”, Nature, London, 1953, 172, 772.Google Scholar
Marrazzi, A. S., and Hart, E. R., “Relationship of hallucinogens to adrenergic cerebral neurohumors”, Science, 1955, 121, 365–367.Google Scholar
Rinaldi, F., and Himwich, H. E., “The cerebral electrographic changes induced by LSD and mescaline are corrected by frenquel”, J. nerv. ment. Dis., 1955, 122, 424–432.CrossRefGoogle Scholar
Sjoerdsma, A., Smith, T. E., Stevenson, T. D., and Udenfriend, S., “Metabolism of 5-hydroxytryptamine (serotonin) by monoamine oxidase”, Proc. soc. exp. Biol., N. Y., 1955, 89, 36–38.CrossRefGoogle Scholar
Taeschler, M., and Cerletti, A., “Some observations on the interaction of reserpine and LSD”, J. Pharm. exp. Ther., 1957, 120, 179–183.Google Scholar
Udenfriend, S., Websbach, H., and Clark, C. T., “The estimation of 5-hydroxytryptamine (serotonin) in biological tissues”, J. biol. Chem., 1955a, 215, 337–344.Google Scholar
Idem , Titus, E., and Weissbach, H., “The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay”, ibid, 1955b, 216, 499–505.Google Scholar
Iidem and Peterson, R. E., “Biogenesis and metabolism of 5-hydroxyindole compounds”, ibid., 1956, 219, 335–344.Google Scholar
Idem , Weissbach, H., and Bogdanski, D. F., “Increase in tissue serotonin following administration of 5-hydroxytryptophan”, ibid., 1957, 224, 803–810.Google Scholar
Woolley, D. W., and Shaw, E., “Some neurophysiological aspects of serotonin”, Brit. med. J., 1954, ii 122–126.Google Scholar
Idem , Van Winkle, E., and Shaw, E., “A method for increasing brain serotonin without incurring some of the peripheral effects of the hormone”, Proc. nat. Acad. Sci., 1957, 43, 128–133.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.